Lifetime risk of dementia and Alzheimer's disease: The impact of mortality on risk estimates in the Framingham Study

Neurology

Volumn 49, Issue 6, 1997, Pages 1498-1504

  Seshadri, S ^a   Wolf, Philip A ^b   Beiser, A ^c   Au, R ^b   McNulty, K ^b   White, R ^b,d   D'Agostino, R B ^e  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Boston University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; DEMENTIA; FEMALE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL; TASK PERFORMANCE;

EID: 0031467629     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.6.1498     Document Type: Article

References (34)

1. Snyder Sachs J. Worrying yourself sick: Alzheimer's anxiety can hit anyone. Longevity, October 1995.
2. Breitner JC. Clinical genetics and genetic counseling in Alzheimer disease. Ann Intern Med 1991;115:601-606.
3. Drachman DA. If we live long enough, will we all be demented? Neurology 1994;44:1563-1565.
4. Sayetta RB. Rates of senile dementia-Alzheimer's type in the Baltimore Longitudinal Study. J Chronic Dis 1986;39:271-286.
5. Seshadri S, Drachman DA, Lippa CL. Apolipoprotein E ∈4 allele and the lifetime risk of Alzheimer's disease: what physicians know and what they should know. Arch Neurol 1995;52: 1074-1079.
6. Farrer LA, Cupples LA. Estimating the probability for major gene Alzheimer disease. Am J Hum Genet 1994;54:374-383.
7. Schoenberg BS, Kokmen E, Okazaki H. Alzheimer's disease and other dementing illnesses in a defined United States population: incidence rates and clinical features. Ann Neurol 1987;22:724-729.
8. Hagnell O, Ojesjo L, Rorsman B. Incidence of dementia in the Lundby study. Neuroepidemiology 1992;11(suppl 1):61-66.
9. Hagnell O, Franck A, Grasbeck A, et al. Senile dementia of the Alzheimer type in the Lundby study. I. A prospective, epidemiological study of the incidence and risk during the 15 years 1957-1972. Eur Arch Psychiatry Clin Neurosci 1991; 241:159-164.
10. Hebert LE, Scherr PA, Beckett LA, et al. Age-specific incidence of Alzheimer's disease in a community population. JAMA 1995;273:1354-1359.
11. Schouten LJ, Straatman H, Kiemeney LALM, Verb ALM. Cancer incidence: life table risk versus cumulative risk. J Epidemiol Comm Health 1994;48:596-600.
12. Farmer ME, White LR, Kittner SJ, et al. Neuropsychological test performance in Framingham: a descriptive study. Psychol Rep 1987;60:1023-1040.
13. Folstein M, Folstein SE, Mchugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
14. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994.
15. Mckhann G, Drachman DA, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
16. Bachman DL, Wolf PA, Linn R, et al. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 1992;42:115-119.
17. Bachman DL, Wolf PA, Linn RT, et al. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology 1993;43:515-519.
18. Aalen O. Nonparametric estimation of partial transition probabilities in multiple decrement models. Ann Stat 1978;6:534-545.
19. Gaynor JJ, Feuer EJ, Tan CC, et al. On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. J Am Stat Assoc 1993;88:400-409.
20. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
21. Bryant HE, Brasher PMA. Risks and probabilities of breast cancer: short-term versus lifetime probabilities. Can Med Assoc J 1994;150:211-216.
22. Feuer EJ, Wun LM, Boring CC, Dana Flanders W, Timmel MJ, Tong T. The lifetime risk of developing breast cancer. J Natl Cancer Inst 1993;85:892-897.
23. Brenner H, Stegmaier C, Ziegler H. Magnitude and time trends of the life-time risk of developing cancer in Saarland, Germany. Eur J Cancer 1990;26:978-982.
24. Bender AP, Punyko J, Williams AN, Bushhouse SA, and the Section of Chronic Disease and Environmental Epidemiology, Minnesota Department of Health. A standard person-years approach to estimating lifetime cancer risk. Cancer Causes and Control 1992;3:69-75.
25. Black DM, Cummings SR, Melton JL III. Appendicular bone mineral and a women's lifetime risk of hip fracture. J Bone Miner Res 1992;7:639-646.
26. Lauritzen JB, Schwarz P, Lund B, McNair P, Transbol I. Changing incidence and residual lifetime risk of common osteoporosis-related fractures. Osteoporosis Int 1993;3:127-132.
27. Arenberg D. Misclassification of "probable senile dementia of the Alzheimer type" in the Baltimore Longitudinal Study of Aging. J Clin Epidemiol 1990;43:105-107.
28. National Center for Health Statistics. Vital Statistics of the United States, 1989: Mortality, part A. Washington, DC: Public Health Service; 1993;2:2. [Public Health Service publication 93-1101.]
29. National Institute on Aging/Alzheimer's Association Working Group. Apolipoprotein E genotyping in Alzheimer's disease -consensus statement. Lancet 1996;347:1091-1095.
30. Myers RH, Schaefer EJ, Wilson PWF, et al. Apolipoprotein E ∈4 association with dementia in a population-based study: the Framingham Study. Neurology 1996;46:673-677.
31. Lee PN. Smoking and Alzheimer's disease: a review of the epidemiological evidence. Neuroepidemiology 1994;13:131-134.
32. Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995;273:1274-1278.
33. Hofman A, Bots ML, Breteler MMB, Ott A, Grobee DE. Atherosclerosis and dementia: the Rotterdam Study [abstract]. Neurology 1995;45(suppl 4):A214.
34. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology 1995;45: 461-466.